Clinical Trial Update: VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for VBI-S aiming to treat hypotension in hypovolemic septic shock patients is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• VBI-S

Snippet

Sponsor: Vivacelle Bio | Conditions: Septic Shock, Sepsis | Phase 2 | Status: UNKNOWN